Treatment of attention-deficit/hyperactivity disorder

Details Treatment of attention-deficit/hyperactivity disorder Treatment of attention-deficit/hyperactivity disorder

A - Human Necessities

61

K

A61K 31/38 (2006.01) A61K 31/135 (2006.01) A61K 31/138 (2006.01) A61K 31/381 (2006.01)

Patent

CA 2227410

A group of propanamines, norepinephrine uptake inhibitors, are used to treat attention-deficit/hyperactivity disorder.

L'invention porte sur un groupe de propanamines, des inhibiteurs de l'absorption des norépinéphines, utilisées dans le traitement de troubles liés au déficit de l'attention et à l'hyperactivité.

Affiliated with

Also associated with

Rating

Treatment of attention-deficit/hyperactivity disorder does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of attention-deficit/hyperactivity disorder, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of attention-deficit/hyperactivity disorder will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2061085